Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

268.32
+2.931.10%
Post-market: 268.320.00000.00%19:54 EDT
Volume:1.30M
Turnover:346.05M
Market Cap:18.84B
PE:46.39
High:268.97
Open:263.47
Low:258.25
Close:265.39
Loading ...

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.
·
4 hours ago

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks
·
Yesterday

Insulet Corp - on March 20, Enters Seventh Amendment to Credit Agreement - SEC Filing

THOMSON REUTERS
·
21 Mar

Insulet’s Strong Performance and Growth Prospects Drive Buy Rating

TIPRANKS
·
21 Mar

Insulet’s Omnipod 5 Gains Favorable Buy Rating Following RADIANT Study Success

TIPRANKS
·
20 Mar

Insulet’s Strategic Debt Restructuring: Buy Rating Reaffirmed Amid Margin and EPS Growth Prospects

TIPRANKS
·
20 Mar

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System

MT Newswires Live
·
20 Mar

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
20 Mar

BRIEF-Insulet’s radiant trial demonstrates glycemic improvements with Omnipod® 5 automated insulin delivery system

Reuters
·
20 Mar

Insulet’s Radiant Trial Demonstrates Meaningful Glycemic Improvements With the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition From Multiple Daily Injections

THOMSON REUTERS
·
20 Mar

BRIEF-Insulet announces pricing of senior notes due 2033

Reuters
·
19 Mar

Insulet Corp - Prices $450 Million Senior Unsecured Notes Due 2033

THOMSON REUTERS
·
19 Mar

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey
·
19 Mar

Insulet Plans $450 Million Senior Notes Offering

MT Newswires Live
·
18 Mar

Insulet Corp - to Amend Credit Agreement, Extend Maturity to 2030

THOMSON REUTERS
·
18 Mar

Insulet Corp - Proceeds to Partially Terminate 0.375% Convertible Senior Notes Due 2026

THOMSON REUTERS
·
18 Mar